Hemostatic Disorders  >>  VRDN-001  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
VRDN-001 / Viridian Therap
NCT01233895: Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma

Completed
1
26
Europe
AVE1642, Velcade, Bortezomib
Sanofi
Multiple Myeloma
09/08
09/08

Download Options